5 reduced cytotoxicity of TAC on the Neuro-2a cell line. Moreover, in vivo co-administration of both DG4.0-TAC and DG4.5-TAC reduced the morphological and hepatotoxic effects of TAC in zebrafish larvae. The reduction of TAC toxicity was not accompanied by a reduction in its activity since the anti-acetylcholinesterase activity remains when it is…[Read more]

5 reduced cytotoxicity of TAC on the Neuro-2a cell line. Moreover, in vivo co-administration of both DG4.0-TAC and DG4.5-TAC reduced the morphological and hepatotoxic effects of TAC in zebrafish larvae. The reduction of TAC toxicity was not accompanied by a reduction in its activity since the anti-acetylcholinesterase activity remains when it is…[Read more]

5 reduced cytotoxicity of TAC on the Neuro-2a cell line. Moreover, in vivo co-administration of both DG4.0-TAC and DG4.5-TAC reduced the morphological and hepatotoxic effects of TAC in zebrafish larvae. The reduction of TAC toxicity was not accompanied by a reduction in its activity since the anti-acetylcholinesterase activity remains when it is…[Read more]

We solve the STAR model by an alternating optimization algorithm. Each sub-problem is transformed into a vectorized least squares regression, with closed-form solutions. Comprehensive experiments on commonly tested datasets demonstrate that, the proposed STAR model produce better quantitative and qualitative performance than previous competing…[Read more]

We solve the STAR model by an alternating optimization algorithm. Each sub-problem is transformed into a vectorized least squares regression, with closed-form solutions. Comprehensive experiments on commonly tested datasets demonstrate that, the proposed STAR model produce better quantitative and qualitative performance than previous competing…[Read more]